Q3695541 (Q3695541): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Created claim: summary (P836): Acquisition of a UHPLC-HRMS equipment dedicated to high-throughput lipid analysis in order to carry out non-targeting research (or profiling) of lipid biomarkers, i.e. to map and compare all the lipids constituting a population with a pathology (subjects with digestive cancers, cardiovascular diseases, neurodegenerative diseases, infections, diabetes...) in relation to a control population., translated_summary) |
||||||||||||||
Property / summary | |||||||||||||||
Acquisition of a UHPLC-HRMS equipment dedicated to high-throughput lipid analysis in order to carry out non-targeting research (or profiling) of lipid biomarkers, i.e. to map and compare all the lipids constituting a population with a pathology (subjects with digestive cancers, cardiovascular diseases, neurodegenerative diseases, infections, diabetes...) in relation to a control population. (English) | |||||||||||||||
Property / summary: Acquisition of a UHPLC-HRMS equipment dedicated to high-throughput lipid analysis in order to carry out non-targeting research (or profiling) of lipid biomarkers, i.e. to map and compare all the lipids constituting a population with a pathology (subjects with digestive cancers, cardiovascular diseases, neurodegenerative diseases, infections, diabetes...) in relation to a control population. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: Acquisition of a UHPLC-HRMS equipment dedicated to high-throughput lipid analysis in order to carry out non-targeting research (or profiling) of lipid biomarkers, i.e. to map and compare all the lipids constituting a population with a pathology (subjects with digestive cancers, cardiovascular diseases, neurodegenerative diseases, infections, diabetes...) in relation to a control population. (English) / qualifier | |||||||||||||||
point in time: 22 November 2021
|
Revision as of 10:31, 22 November 2021
Project Q3695541 in France
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3695541 in France |
Statements
173,604.24 Euro
0 references
396,894.54 Euro
0 references
43.74 percent
0 references
18 March 2016
0 references
31 October 2018
0 references
Université de Bourgogne
0 references
Acquisition d'un équipement UHPLC-HRMS dédié à l’analyse haut débit de lipides afin de faire une recherche non ciblée (ou profiling) de biomarqueurs lipidiques, c'est-à-dire à cartographier et comparer l’ensemble des lipides constitutifs d’une population présentant une pathologie (sujets atteints de cancers digestifs, maladies cardiovasculaires, neurodégénératives, infections, diabète …) par rapport à une population témoin. (French)
0 references
Acquisition of a UHPLC-HRMS equipment dedicated to high-throughput lipid analysis in order to carry out non-targeting research (or profiling) of lipid biomarkers, i.e. to map and compare all the lipids constituting a population with a pathology (subjects with digestive cancers, cardiovascular diseases, neurodegenerative diseases, infections, diabetes...) in relation to a control population. (English)
22 November 2021
0 references
Identifiers
BG0007227
0 references